In a report published Thursday, Deutsche Bank analyst Darren Lehrich reiterated a Hold rating and $104.00 price target on Mednax MD.
In the report, Deutsche Bank noted, “Overall, Q3 results were mostly in-line with expectations, with EPS $1.52 vs. guidance of $1.46-$1.51 and Street consensus $1.48 / DBe $1.46. EPS was helped $0.06/sh by parity payments (vs. guidance $0.05/sh) and $0.04/sh by lower tax rate. Q4 guidance was initiated in-line with expectations. MD also announced a shelf filing, which we believe signals bigger M&A activity in development pipeline.”
Mednax closed on Wednesday at $105.75.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in